Insider Trading February 24, 2026

Regency Centers Executive Chairman Disposes $763,001 in Shares

Martin E. Stein Jr. sold 10,000 Regency Centers shares; company posts mixed Q4 2025 results and sizes a 2033 note offering

By Jordan Park REG
Regency Centers Executive Chairman Disposes $763,001 in Shares
REG

Martin E. Stein Jr., executive chairman of Regency Centers Corp, reported the sale of 10,000 shares on February 20, 2026 via a Form 4 filing. The disposition totaled $763,001 at a weighted average price of $76.3001. The filing details Stein's remaining direct holdings and various indirect ownership vehicles. Separately, Regency reported stronger-than-expected EPS for Q4 2025 but missed revenue estimates and announced a $450 million unsecured note offering due 2033.

Key Points

  • Martin E. Stein Jr. sold 10,000 Regency Centers shares on February 20, 2026 for $763,001 at a weighted average price of $76.3001; sale prices ranged from $76.10 to $76.42.
  • Following the sale Stein directly owns 272,133 shares and has additional indirect holdings via family trusts, a family-controlled corporation, two general partnerships and a personal trust; the Form 4 was signed by Michael R. Herman on February 24, 2026.
  • Regency reported Q4 2025 EPS of $1.12 versus a forecast of $0.57 and revenue of $395.41 million, missing expectations of $404.31 million by 2.2%; the company also priced $450 million of senior unsecured notes due 2033 at a 4.50% coupon.

Martin E. Stein Jr., who serves as executive chairman of Regency Centers Corp (NASDAQ: REG), recorded a sale of 10,000 shares of common stock on February 20, 2026, according to a Form 4 filed with the Securities and Exchange Commission.

The filing states the shares were sold at a weighted average price of $76.3001, producing gross proceeds of $763,001. Reported execution prices for the shares ranged between $76.10 and $76.42. After the transaction, Stein is shown as the direct holder of 272,133 shares of Regency Centers common stock.

The Form 4 further outlines Stein's indirect ownership stakes. These include interests held through a trust where his adult children are beneficiaries, a corporation controlled by his family, two general partnerships in which he is a general partner, and a trust established for his benefit. The filing was executed by Michael R. Herman, Attorney-in-Fact, and signed on February 24, 2026.


The insider sale occurred while Regency Centers shares were trading at $77.41, close to a 52-week high of $78.25. An InvestingPro analysis cited in the filing notes that the stock appears overvalued at current levels. The filing also points investors to a comprehensive Pro Research Report available for REG and more than 1,400 other U.S. equities for those seeking further analysis.

Corporate results and financing moves were disclosed alongside the insider transaction. Regency Centers reported fourth-quarter 2025 earnings per share of $1.12, outpacing the consensus forecast of $0.57. Revenue for the quarter came in at $395.41 million, missing the $404.31 million estimate by roughly 2.2 percent.

In the capital markets, Regency priced a $450 million offering of senior unsecured notes maturing in 2033. The notes carry a 4.50% coupon and were issued at 99.376% of par value.

Market analysts adjusted their outlook following the quarterly disclosures. Ladenburg Thalmann raised its price target on Regency Centers to $80.00 from $76.00 while maintaining a Neutral rating. The firm’s update followed the company’s reported fourth-quarter NAREIT funds from operations (FFO) of $1.17 per share, which matched consensus estimates. Regency’s Core FFO was reported at $1.12 per share, a penny below Ladenburg Thalmann’s projection.

On the governance front, the company disclosed that director C. Ronald Blankenship intends to retire after the 2026 annual meeting of shareholders. Regency Centers explicitly stated that his planned retirement is not the result of any disagreement with the company concerning its operations, policies, or practices.


These disclosures - an insider sale, quarterly operating results with mixed beats and misses, a debt offering and a board retirement - together reflect active financial and governance developments at Regency Centers. Investors will be able to review the Form 4 and the company’s earnings and financing details to assess any implications for ownership, capital structure and near-term financial metrics.

Risks

  • Insider selling may prompt investor scrutiny of executive sentiment toward the stock - this impacts the real estate investment trust and equity markets.
  • Revenue for Q4 2025 missed consensus estimates by 2.2%, introducing uncertainty about near-term operating performance in the real estate sector.
  • Issuance of $450 million in senior unsecured notes alters Regency’s debt profile and introduces refinancing and interest-rate considerations for fixed-income markets.

More from Insider Trading

Progressive Accounting Chief Disposes $55K in Stock as Shares Trade Near Yearly Low Mar 23, 2026 Old Second Bancorp Vice Chairman Disposes $429K in Shares; Ownership Stakes and Recent Results Also Detailed Mar 23, 2026 Vicor Chairman Disposes $7.9 Million in Stock; Transaction Executed Under 10b5-1 Plan Mar 23, 2026 Nutex Health President Buys $23,706 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026 Nutex Health Director Buys $14,033 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026